Paulus Kirchhof: Left Atrial Appendage Occlusion vs DOACs
Paulus Kirchhof, Professor of Medicine (Cardiology) and Director of the Department of Cardiology at the University Medical Center Hamburg-Eppendorf, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of the American College of Cardiology (JACC), adding:
“Do left atrial appendage occluders reduce major bleeding events compared to DOACs?
You may think ‘yes of course’, but the reality is more nuanced when you put that hypothesis to the test in controlled clinical trials. Find out more in a recently published individual patient data meta analysis of the CLOSURE-AF and PRAGUE-17 trials.
These signals illustrate the power of investigator-initiated research. Time to reconsider and refine management strategies. And time to thank the public funders, including the German Government, for their support for this important type of research.”
Title: Left Atrial Appendage Closure in Atrial Fibrillation Patients With High Risk of Stroke and Bleeding: An Individual Participant Data Meta-Analysis of Randomized Trials
Authors: Carsten Skurk, Ingo Eitel, Tharusan Thevathasan, Petr Neuzil, Paulus Kirchhof, Holger Thiele, Marcus Sandri, Andreas Zeiher, David Leistner, Andreas Rillig, Manuela Licka, Norbert Frey, Jörg Hausleiter, Steffen Massberg, Erlon Xhepa, Karl Georg Haeusler, Matthias Endres, Miriam Puls, Klara Benesova, Tim Friede, Karl Wegscheider, Leif-Hendrik Boldt, Vivek Y. Reddy, Pavel Osmancik, Ulf Landmesser

Other posts featuring Paulus Kirchhof on Hemostasis Today.
-
Nov 21, 2026, 13:06Christine Faressa: Precision PRP and Platelet Biology in Musculoskeletal Care
-
Nov 21, 2026, 13:04Eyad Jamileh: Atrial Fibrillation – Bridging the Global Gaps in Diagnosis and Stroke Prevention
-
Nov 21, 2026, 12:49Thibault Veyron: Optimizing Bivalirudin Treatment in HIT
-
Nov 21, 2026, 12:19Jiyeon Kim: Human Platelet Lysate – Advancing Cell Therapy and Space Research
-
Nov 21, 2026, 12:13Chaza Alaji: DVT in Early Pregnancy – Why Anticoagulation Decisions Matter
-
Nov 21, 2026, 12:06Salih Ehsan: Why Iron Therapy May Not Work
-
Nov 21, 2026, 11:59Edward Lee Carter: DOACs vs Warfarin for LV Thrombus – Are We Getting Closer to an Answer?
-
Nov 21, 2026, 11:50Abdul Mannan: When G6PD Testing Misleads During Acute Hemolysis
-
Nov 21, 2026, 11:36Emma Copperwaite: Transforming the Transfusion Pathway Through Digital Innovation